The immunohistochemical assay showed that the expression level of the AKR1C1 protein in metastatic tumors was significantly elevated compared to the corresponding primary tumors (Figure 3C), suggesting that higher AKR1C1 expression is associated with metastasis in NSCLC. Here, AKR1C1 is linked to metastatic neoplasm.